KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,716,661 | -49.5% | 339,328 | -16.4% | 0.00% | -100.0% |
| Q2 2023 | $9,331,755 | -3.5% | 405,905 | +24.4% | 0.00% | 0.0% |
| Q1 2023 | $9,668,921 | +62.9% | 326,322 | +37.2% | 0.00% | 0.0% |
| Q4 2022 | $5,935,538 | +57.9% | 237,802 | +37.7% | 0.00% | 0.0% |
| Q3 2022 | $3,760,000 | -42.9% | 172,750 | -48.3% | 0.00% | 0.0% |
| Q2 2022 | $6,580,000 | -16.2% | 334,149 | +80.2% | 0.00% | 0.0% |
| Q1 2022 | $7,850,000 | +50.6% | 185,483 | +125.9% | 0.00% | 0.0% |
| Q4 2021 | $5,214,000 | +1.4% | 82,125 | -6.2% | 0.00% | 0.0% |
| Q3 2021 | $5,142,000 | +66.5% | 87,561 | +37.5% | 0.00% | – |
| Q2 2021 | $3,089,000 | -77.3% | 63,688 | -81.8% | 0.00% | -100.0% |
| Q1 2021 | $13,630,000 | +1157.4% | 350,740 | +1906.2% | 0.00% | – |
| Q4 2020 | $1,084,000 | +627.5% | 17,483 | +277.8% | 0.00% | – |
| Q3 2020 | $149,000 | – | 4,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |